Aperam confirms lower Q3 outlook for Aperam stock

Published on 10/19/2026 at 09:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Aperam expects Q3 adjusted EBITDA below EUR 130.00 million. Aperam stock costs EUR 37.63 on October 19, 2026 ahead of November 6 results.

Earnings pressure and valuation

The October 6, 2026 update put third-quarter adjusted EBITDA at EUR 113.00 million by company consensus.
JPMorgan cut its target from EUR 57.00 to EUR 55.50 on October 15, 2026.
Aperam stock traded at EUR 37.63 at 9:19 a.m. CEST at Lang & Schwarz on October 19, 2026.
The market capitalization stood at EUR 2.7 billion as of October 19, 2026.

Aperam, LU0569974404, Illustration mit AI erstellt.

Aperam (ISIN LU0569974404) confirmed on October 6, 2026 that adjusted EBITDA for the third quarter would fall below the EUR 130.00 million achieved in the second quarter, according to FT. The update also set the company-compiled consensus at EUR 113.00 million for the quarter.

Why is the Q3 bar lower?

Aperam expects the sequential decline because of seasonal effects, while its October update described European demand as low and order books as unchanged. The same release said third-quarter adjusted EBITDA should remain above the EUR 90.00 million recorded in the first quarter, creating a range between the first and second quarters rather than a full earnings recovery.

The financial backdrop is mixed. Aperam reported EUR 3.264 billion in revenue, EUR 249.00 million in EBITDA and EUR 119.00 million in net income for the first half of 2026, figures reported by Ideal Investisseur.

What changed in three dated steps?

On July 30, 2026, the first-half report put revenue at EUR 3.264 billion. On October 6, 2026, the company set the third-quarter adjusted EBITDA comparison at below EUR 130.00 million but above EUR 90.00 million. On October 15, 2026, JPMorgan lowered its price target from EUR 57.00 to EUR 55.50 and retained an Overweight rating, as Markets Insider reported.

Which dates come next?

Aperam is scheduled to publish third-quarter and nine-month 2026 results on November 6, 2026, followed by a conference call at 2:00 p.m. CET. The company also lists a capital markets day in Paris for November 18, 2026, according to the October 6 announcement.

Price stays near the recent floor

The stock's current market setting adds a cautious counterpoint to the analyst target. Aperam had a market capitalization of EUR 2.7 billion and a 52-week range of EUR 29.50 to EUR 53.85 as of October 19, 2026, leaving the quote in the lower half of that range.

Aperam was trading at EUR 37.63 at Lang & Schwarz on October 19, 2026 at 9:19 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Aperam stock.